TATRU
Active compound · Orange line
TATRU is a molecule designed to simultaneously activate the GIP, GLP-1 and glucagon receptors, reducing appetite, increasing satiety and regulating blood glucose. This three-pathway combination sets it apart from other peptides in its category. Lyophilized peptide in vial presentation, available in 5 mg, 10 mg and 20 mg — select the formulation that fits your protocol below.
Compound class Triple receptor agonist Molecular target GIP · GLP-1 · Glucagon Presentation Lyophilized vial + 2 ml Bac. water User satisfaction 98 %
Showing all 3 results
